Cargando…

Ankaferd hemostat: from molecules to medicine

Ankaferd hemostat (ABS; Ankaferd Blood Stopper®, İstanbul, Turkey) is a hemostatic agent having an impact on red blood cell–fibrinogen interactions. The hemostatic effect of ABS depends upon the quick promotion of a protein network, particularly fibrinogen gamma, in relation to the erythrocyte aggre...

Descripción completa

Detalles Bibliográficos
Autores principales:	ÇİFTÇİLER, Rafiye, HAZNEDAROĞLU, İbrahim Celalettin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672348/ https://www.ncbi.nlm.nih.gov/pubmed/32283900 http://dx.doi.org/10.3906/sag-1908-161

Ejemplares similares

Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2019)

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)
por: Ciftciler, Rafiye, et al.
Publicado: (2020)

Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2019)

Antineoplastic Effects of Ankaferd Hemostat
por: Malkan, Umit Yavuz, et al.
Publicado: (2022)

Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat
por: HAZNEDAROĞLU, İbrahim Celalettin, et al.
Publicado: (2020)

Endothelial Cells, Ankaferd Hemostat, and Estradiol
por: Ardıçoğlu, Yasemin, et al.
Publicado: (2016)

Pathobiological Interactions of Local Bone Marrow Renin-Angiotensin System and Central Nervous System in Systemic Arterial Hypertension
por: Ciftciler, Rafiye, et al.
Publicado: (2020)

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
por: Turk, Seyhan, et al.
Publicado: (2017)

The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine
por: Okay, Mufide, et al.
Publicado: (2019)

Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids
por: Koluman, Ahmet, et al.
Publicado: (2016)

Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases
por: Koluman, Ahmet, et al.
Publicado: (2017)

A New Candidate as a Hemostatic Agent for Difficult Situations During Variceal Bleeding: Ankaferd Blood Stopper
por: Ozaslan, Ersan, et al.
Publicado: (2011)

COVID-19, Renin-Angiotensin System, and Hematopoiesis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

On Being a “Physician Patient” with His Own Experimental Therapeutic Drug
por: Çiftçiler, Rafiye, et al.
Publicado: (2018)

Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach
por: Koçak, Engin, et al.
Publicado: (2019)

Oral High-Dose Ankaferd Administration Effects on Gastrointestinal System
por: Akbal, Erdem, et al.
Publicado: (2013)

The Factors Affecting Early Death in Newly Diagnosed APL Patients
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
por: Çiftçiler, Rafiye, et al.
Publicado: (2021)

Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content
por: Beyazit, Fatma, et al.
Publicado: (2020)

In Vitro Efficacy of the Ankaferd Galenic Hemostatic Extract as a Germicidal Agent
por: METİN, Bayram, et al.
Publicado: (2016)

Generation of Chimeric “ABS Nanohemostat” Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model
por: Huri, Emre, et al.
Publicado: (2013)

Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper
por: Simsek, Cem, et al.
Publicado: (2017)

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
por: Çiftçiler, Rafiye, et al.
Publicado: (2019)

Effect of the plant-based hemostatic agent Ankaferd Blood Stopper® on the biocompatibility of mineral trioxide aggregate
por: Dinçol, Muzaffer Emir, et al.
Publicado: (2016)

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
por: OKAY, Müfide, et al.
Publicado: (2019)

Comparison of bortezomibcyclophosphamide- dexamethasone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients
por: Ciftciler, Rafiye, et al.
Publicado: (2020)

Comparison of hemostatic efficacy of topical Ankaferd Blood Stopper on heparinized and nonheparinized rats in bleeding related to liver injury
por: Ergin, Metin, et al.
Publicado: (2021)

Indications and Outcomes of Splenectomy for Hematological Disorders
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
por: Karabıyık, Afife, et al.
Publicado: (2012)

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, ankaferd blood stopper, on vascular tissue in a rat aortic bleeding model
por: Kandemir, Ozer, et al.
Publicado: (2010)

The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial
por: Kazancıoğlu, Hakkı Oğuz, et al.
Publicado: (2013)

Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
por: Demiroğlu, Haluk, et al.
Publicado: (2021)

Effects of folk medicinal plant extract Ankaferd Blood Stopper(®) on early bone healing
por: İŞLER, Sabri Cemil, et al.
Publicado: (2010)

Current perspectives for the treatment of chronic myeloid leukemia
por: ALADAĞ, Elifcan, et al.
Publicado: (2019)

Effect of ankaferd blood stopper in experimental peritoneal adhesion model
por: Karaca, Gokhan, et al.
Publicado: (2016)

Assessment of Ankaferd Blood Stopper in experimental liver ischemia reperfusion injury
por: DURHAN, Abdullah, et al.
Publicado: (2020)

The effect of Ankaferd blood stopper on liver damage in experimental obstructive jaundice
por: KOŞMAZ, Koray, et al.
Publicado: (2021)

Drug interaction potential of Ankaferd blood stopper(®) in human hepatocarcinoma cells
por: SEMİZ, Aslı
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g1avthmhj3teqejn6r35t95hgh